Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intestinal Current Measurements (ICM) to Evaluate the Activation of Mutant CFTR in Subjects With Cystic Fibrosis Aged 12 Years and Older, Homozygous for the p.Phe508del-CFTR Mutation, Treated With Lumacaftor in Combination With Ivacaftor

NCT02807415 is registered in ClinicalTrials.gov with Hannover Medical School as lead sponsor.

NCT NCT02807415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02807415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intestinal Current Measurements (ICM) to Evaluate the Activation of Mutant CFTR in Subjects With Cystic Fibrosis Aged 12 Years and Older, Homozygous for the p.Phe508del-CFTR Mutation, Treated With Lumacaftor in Combination With Ivacaftor
Lead sponsor
Hannover Medical School
Phase
Observational
Overall status
Completed
Start date
June 1, 2016
Completion date
February 10, 2020
Enrollment
104 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis